CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -100.0% | 1,031 | -56.3% | 0.00% | – |
| Q3 2022 | $22,000 | -4.3% | 2,361 | -7.9% | 0.00% | – |
| Q2 2022 | $23,000 | -17.9% | 2,564 | +9.7% | 0.00% | – |
| Q1 2022 | $28,000 | 0.0% | 2,338 | +0.1% | 0.00% | – |
| Q4 2021 | $28,000 | -22.2% | 2,335 | 0.0% | 0.00% | – |
| Q3 2021 | $36,000 | +71.4% | 2,335 | +52.6% | 0.00% | – |
| Q2 2021 | $21,000 | 0.0% | 1,530 | +53.0% | 0.00% | – |
| Q1 2021 | $21,000 | -65.0% | 1,000 | -75.0% | 0.00% | – |
| Q4 2020 | $60,000 | -4.8% | 4,000 | -20.0% | 0.00% | -100.0% |
| Q3 2020 | $63,000 | -26.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $86,000 | +30.3% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $66,000 | -54.5% | 5,000 | -44.4% | 0.00% | -50.0% |
| Q4 2019 | $145,000 | -12.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $165,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |